KnowTheStock
Log inCreate free account

ELI LILLY & Co

LLY
S&P 500Pharmaceutical Preparations · NYSE
$1.00last close · market cap 893.40 Million
Compare with…
77.4SCORE / 100
Our verdictHOLDStrong Growth and ImprovingQtr Ending 2026-09-30 · trend positive

Why Hold

Income statement and cash flow are strong; balance sheet is moderate.

Next earnings: 2026-10-29 (BMO), EPS Forecast: $5.38

What is strong
  • Revenue Growth is 45.51%
  • Operating Income Growth is 67.92%
  • Net Income Growth is 49.79%
  • Earnings Per Share (EPS) Growth is 50.81%
  • Net Margin is 31.9%
  • Current Debt to Net Income Ratio is 0.39
  • Total Debt to Total Assets Ratio is 0.33
  • Cash from Operations Growth is 90.79%
  • Capital Expenditure is Low
What to watch
  • Current Asset to Current Liability Ratio is 1.39
  • Debt Ratio is 0.73
  • Net Increase in Cash is Negative

What changed

Score by quarter

Upgraded from Sell to Hold in the Jun 2024 quarter: 64.5 → 65.5 (+1.0). This quarter: +1.3.

50607080Mar 2023Sep 2026

What the score is made of

Income statement89.3 +0.1
Balance sheet57.0 +4.2
Cash flow74.4 +0.0

Change vs previous quarter.

Key numbers · latest quarter

Revenue (TTM)86.46 Billion45.51 % growth
EPS30.8150.81 % growth
Profit margin31.90 %Profit per $1 of sales
P-E ratio—Not available
Market cap893.40 MillionShares × price
Debt-equity ratio1.23Leverage
Dividend6.69Per share, annual
Next earnings2026-10-29BMO · EPS forecast $5.38
Better viewed in landscape mode.
Unless specified, all values are in USD Millions. Data extracted from SEC Filing and are subject to processing and input errors.

About ELI LILLY & Co

Lilly is a global health care leader that unites caring with discovery to create medicines that make life better for people around the world. It was founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today it remains true to that mission in all its work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism.

CEO
David Ricks
Employees
2,020
Sector
Manufacturing
Exchange
NYSE
www.lilly.com

Similar stocks

Loading…